Endothelin and skeletal metastases in hormone-refractory prostate cancer
Skeletal metastases represent a major complication of advanced hormone-refractory prostate cancer (HRPC). These lesions affect around 85% of patients and provide a poor quality of life due to associated pathological fractures, spinal compression and pain. Metastatic HRPC is incurable and typically f...
| Main Author: | |
|---|---|
| Format: | Conference item |
| Published: |
2003
|